|
Oxygenta Pharmaceutical Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
219.31 Cr.
|
P/BV
|
-11.17
|
Book Value (Rs.)
|
-5.31
|
|
52 Week High/Low (Rs.)
|
134/54
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2019
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -2.69 | -1.09 | -8.15 | -0.48 | 2.87 |
| Diluted EPS (Rs.) | -2.69 | -1.04 | -8.15 | -0.48 | 2.87 |
| Cash EPS (Rs.) | -2.40 | -0.24 | -6.70 | 0.69 | 4.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.77 | -6.01 | -32.53 | -24.38 | -37.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.77 | -6.01 | -32.53 | -24.38 | -37.27 |
| Revenue From Operations / Share (Rs.) | 29.55 | 11.84 | 21.82 | 42.62 | 51.00 |
| PBDIT / Share (Rs.) | -2.35 | -2.88 | -5.00 | 1.04 | 3.86 |
| PBIT / Share (Rs.) | -2.57 | -3.68 | -6.44 | -0.07 | 2.68 |
| PBT / Share (Rs.) | -3.12 | -4.14 | -8.01 | -0.34 | 3.08 |
| Net Profit / Share (Rs.) | -2.62 | -1.04 | -8.15 | -0.42 | 2.87 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -7.94 | -24.35 | -22.90 | 2.44 | 7.56 |
| PBIT Margin (%) | -8.69 | -31.06 | -29.53 | -0.18 | 5.26 |
| PBT Margin (%) | -10.57 | -34.99 | -36.70 | -0.80 | 6.04 |
| Net Profit Margin (%) | -8.85 | -8.77 | -37.34 | -1.00 | 5.63 |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -7.70 |
| Return on Capital Employeed (%) | 391.43 | -41.74 | -37.43 | -0.47 | 16.72 |
| Return On Assets (%) | -11.60 | -5.50 | -21.32 | -1.95 | 8.65 |
| Long Term Debt / Equity (X) | -0.86 | -2.44 | -1.36 | -1.47 | -1.18 |
| Total Debt / Equity (X) | -2.49 | -2.84 | -1.47 | -1.51 | -1.26 |
| Asset Turnover Ratio (%) | 1.49 | 0.67 | 0.72 | 1.86 | 1.98 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.36 | 0.71 | 0.83 | 1.19 | 0.91 |
| Quick Ratio (X) | 0.12 | 0.30 | 0.44 | 0.28 | 0.21 |
| Inventory Turnover Ratio (X) | 6.39 | 2.76 | 2.96 | 4.40 | 5.26 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -4.88 | -6.06 | -4.77 | 1.60 | 2.21 |
| Interest Coverage Ratio (Post Tax) (%) | -4.28 | -1.21 | -6.28 | -0.25 | 1.42 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 356.35 | 154.20 | 119.86 | 86.13 | 54.89 |
| EV / Net Operating Revenue (X) | 3.26 | 3.89 | 3.87 | 1.42 | 1.05 |
| EV / EBITDA (X) | -41.03 | -15.97 | -16.88 | 58.17 | 13.95 |
| MarketCap / Net Operating Revenue (X) | 2.69 | 2.45 | 1.68 | 0.56 | 0.14 |
| Price / BV (X) | -11.76 | -4.82 | -1.13 | -0.98 | -0.19 |
| Price / Net Operating Revenue (X) | 2.69 | 2.45 | 1.68 | 0.56 | 0.14 |
| EarningsYield | -0.03 | -0.03 | -0.22 | -0.01 | 0.39 |
